The natural history of EGFR and EGFRvIII in glioblastoma patients

被引：0
|
作者：
Amy B Heimberger
Dima Suki
David Yang
Weiming Shi
Kenneth Aldape
机构：
[1] The Brain Tumor Center,Department of Neurosurgery
[2] The University of Texas M. D. Anderson Cancer Center,Pathology, The Brain Tumor Center
[3] The University of Texas M. D. Anderson Cancer Center,undefined
来源：
Journal of Translational Medicine | / 3卷
关键词：
Glioma; survival; sub-total resection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] DISTINCT FUNCTIONAL ROLES OF WILD-TYPE EGFR AND ITS MUTANT EGFRVIII IN GLIOBLASTOMA DEVELOPMENT
    Miletic, H.
    Rosland, G. V.
    Eskilsson, E.
    Vaelk, K.
    Keunen, O.
    Jahedi, R.
    Azuaje, F.
    Stieber, D.
    Foerster, S.
    Ritter, C.
    NEURO-ONCOLOGY, 2014, 16
  • [32] RESPONSE OF RECURRENT GLIOBLASTOMA IN PATIENTS WITH PTEN CONSERVATE AND EGFRVIII TO TARCEVA
    Gallego, Oscar
    Benavides, M.
    Segura, P. P.
    Balana, C.
    Gil Gil, M. J.
    Berrocal, A.
    Reynes, G.
    Garcia, J. L.
    Mazarico, J.
    Bague, S.
    NEURO-ONCOLOGY, 2010, 12 : 57 - 57
  • [33] RESPONSE OF RECURRENT GLIOBLASTOMA TO TARCEVA IN PATIENTS WITH PTEN AND EGFRvIII CONSERVATION
    Gallego, Oscar
    Benavides, Manuel
    Segura, Pedro Perez
    Balana, Carme
    Gil, Miguel
    Berrocal, Alfonso
    Reynes, G.
    Garcia, J. L.
    Murata, P.
    Bague, S.
    Quintana, M. J.
    NEURO-ONCOLOGY, 2011, 13 : 48 - 48
  • [34] Targeting EGFRvIII for glioblastoma multiforme
    Yang, Ju
    Yan, Jing
    Liu, Baorui
    CANCER LETTERS, 2017, 403 : 224 - 230
  • [35] The EGFRvIII variant in glioblastoma multiforme
    Gan, Hui K.
    Kaye, Andrew H.
    Luwor, Rodney B.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (06) : 748 - 754
  • [36] EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis
    Chen, Shenbo
    Yang, Liangwang
    Li, Zhengzheng
    Zhuo, Shenghua
    Yan, Bo
    Zhang, Zhaoteng
    Zhang, Jinben
    Feng, Haizhong
    Yang, Kun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (06): : 6055 - 6065
  • [37] DEVELOPMENT OF EGFRVIII AND EGFR DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
    Ruff, Michael
    Sakemura, Reona
    Manriquez-Roman, Claudia
    Hefazi-Torghabeh, Mehrdad
    Schick, Kendall
    Michelle, Cox
    Can, Ismail
    Horvei, Paulina
    Siegler, Elizabeth
    Tapper, Erin
    Kenderian, Saad
    NEURO-ONCOLOGY, 2020, 22 : 65 - 65
  • [38] Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII plus glioblastoma.
    O'Rourke, Donald M.
    Nasrallah, MacLean
    Morrissette, Jennifer J.
    Melenhorst, Jan J.
    Lacey, Simon F.
    Mansfield, Keith
    Martinez-Lage, Maria
    Desal, Arati Suvas
    Brem, Steven
    Maloney, Eileen
    Mohan, Suyash
    Wang, Sumei
    Verma, Gaurav
    Navenot, Jean-Marc
    Shen, Angela
    Zheng, Zhaohui
    Levine, Bruce
    Okada, Hideho
    June, Carl H.
    Maus, Marcela Valderrama
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
    Fontanilles, Maxime
    Marguet, Florent
    Ruminy, Philippe
    Basset, Carole
    Noel, Adrien
    Beaussire, Ludivine
    Viennot, Mathieu
    Viailly, Pierre-Julien
    Cassinari, Kevin
    Chambon, Pascal
    Richard, Doriane
    Alexandru, Cristina
    Tennevet, Isabelle
    Langlois, Olivier
    Di Fiore, Frederic
    Laquerriere, Annie
    Clatot, Florian
    Sarafan-Vasseur, Nasrin
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [40] EGFR PHOSPHORYLATES TUMOR-DERIVED EGFRvIII, DRIVING STAT3/5 AND PROGRESSION IN GLIOBLASTOMA
    Fan, Q-W
    Cheng, C.
    Gustafson, W. C.
    Charron, E.
    Zipper, P.
    Wong, R. A.
    Chen, J.
    Lau, J.
    Knobbe-Thosen, C.
    Weller, M.
    Jura, N.
    Reifenberger, G.
    Shokat, K. M.
    Weiss, W. A.
    NEURO-ONCOLOGY, 2013, 15 : 30 - 30
12345